Biotech research

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Biotech Stocks

Novartis AG (ADR) (NYSE:NVS)’ Leukemia Drug Allowed Priority Review By The FDA

Biotech Movers: Retrophin Inc (NASDAQ:RTRX) and Agios Pharmaceuticals Inc (NASDAQ:AGIO)

Spring Bank Pharmaceuticals Inc. (NASDAQ:SBPH) An Ace Up Gilead Sciences (NASDAQ:GILD)’s Sleeve

TherapeuticsMD Inc (NYSEMKT:TXMD)’s Other Candidate Could Be More Important Than Yuvvexy

Sensor-Enabled CE Mark for TactiCath Contact Force Ablation Catheter Announced By Abbott Laboratories (NYSE:ABT)

Alibaba Group Holding Ltd (NYSE:BABA) AliHealth To Offer Drug Tracking Software

Biotech Movers: Sage Therapeutics (NASDAQ:SAGE) and Dynavax Technologies Corporation (NASDAQ:DVAX)

Big Insider Moves at Majesco Entertainment co. (NASDAQ:COOL), Phillip Frost discloses...

Here’s What’s Happening With Akebia Therapeutics Inc (NASDAQ:AKBA) and Epizyme, Inc....

Coverage For Medtronic plc Ordinary Shares (NYSE:MDT) Micra Approved By Centers...

Why ChemoCentryx Inc (NASDAQ:CCXI) Tanked Today

Here’s Why These Two Biotechs Just Took A Hit: Eli Lilly...

It Has Worked: CVS Health Corp (NYSE:CVS) Says Of Its Exit...

Pfizer Inc. (NYSE:PFE) Settling Celebrex and Bextra Class Action Suit

Bristol-Myers Squibb (NYSE:BMY) Presents Data on All-Oral Hepatitis C Regimen

EDITOR PICKS

Market Morning: Gene Therapy Deregulation, Amazon to the Movies, SEC On...

EnergyFunders is democratizing Oil and Gas Investments. Exclusive Interview with CEO Casey...

Market Morning: Asia Down, India Pummeled, Sears on Death Bed, Turkey...

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY